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Background
Our objective is to develop viral vaccine vectors that will
elicit neutralizing antibodies that are specific for the
functional attachment protein on the HIV particle. To
achieve this goal, we are developing vectors that express
membrane-anchored Env trimers that closely mimic
authentic functional glycoprotein spikes.
Methods
We are using vesicular stomatitis virus (VSV) as a vector
platform for delivery of Env immunogens as transmem-
brane glycoproteins. We have investigated a variety of
vector designs and Env modifications to identify combi-
nations that balance the practical requirement for vector
genetic stability with factors influencing antibody
responses including immunogen abundance, efficient
post-translational processing, and presentation of anti-
genic determinants representative of a functional trimeric
spike.
Results
Substituting domains in Env with analogous regions from
VSV G, we have developed a number of immunogens that
are efficiently expressed and incorporated in the infected
cell plasma membrane, and in most cases, progeny virus
particles. Antigenicity was evaluated using a panel of
monoclonal antibodies specific for various Env epitopes.
Conclusion
We identified modified Env immunogens that contain
determinants for most classes of known broadly neutra-
lizing monoclonal antibodies including those with specifi-
city for the CD4 binding site (b12, PGV04), V3 and
carbohydrate (PGT126), the MPER (2F5 and 4E10), the
glycan shield (2G12), and structures formed by V1/V2
and carbohydrate (PG9, PG16, PGT145). Results from
ongoing immunogenicity studies with vectors encoding
SIV or HIV Env immunogens (subtypes A, B, or C) indi-
cate that the modified trimers elicit antibody responses
in small animals and nonhuman primates, and that some
live vectors induce mucosal antibodies. Study sera are
being analyzed for virus neutralization activity and fine
specificity.
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